1. Home
  2. QLGN vs UK Comparison

QLGN vs UK Comparison

Compare QLGN & UK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • UK
  • Stock Information
  • Founded
  • QLGN 1996
  • UK 2015
  • Country
  • QLGN United States
  • UK China
  • Employees
  • QLGN N/A
  • UK 127
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • UK Business Services
  • Sector
  • QLGN Health Care
  • UK Consumer Discretionary
  • Exchange
  • QLGN Nasdaq
  • UK Nasdaq
  • Market Cap
  • QLGN 2.8M
  • UK 2.2M
  • IPO Year
  • QLGN N/A
  • UK N/A
  • Fundamental
  • Price
  • QLGN $3.16
  • UK $1.05
  • Analyst Decision
  • QLGN
  • UK
  • Analyst Count
  • QLGN 0
  • UK 0
  • Target Price
  • QLGN N/A
  • UK N/A
  • AVG Volume (30 Days)
  • QLGN 10.7K
  • UK 24.2K
  • Earning Date
  • QLGN 08-13-2025
  • UK 07-15-2025
  • Dividend Yield
  • QLGN N/A
  • UK N/A
  • EPS Growth
  • QLGN N/A
  • UK N/A
  • EPS
  • QLGN N/A
  • UK N/A
  • Revenue
  • QLGN N/A
  • UK $23,924,045.00
  • Revenue This Year
  • QLGN N/A
  • UK N/A
  • Revenue Next Year
  • QLGN N/A
  • UK N/A
  • P/E Ratio
  • QLGN N/A
  • UK N/A
  • Revenue Growth
  • QLGN N/A
  • UK N/A
  • 52 Week Low
  • QLGN $2.85
  • UK $0.98
  • 52 Week High
  • QLGN $29.44
  • UK $2.26
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 32.55
  • UK 46.05
  • Support Level
  • QLGN $3.37
  • UK $0.98
  • Resistance Level
  • QLGN $3.70
  • UK $1.12
  • Average True Range (ATR)
  • QLGN 0.21
  • UK 0.05
  • MACD
  • QLGN -0.05
  • UK 0.00
  • Stochastic Oscillator
  • QLGN 0.00
  • UK 49.93

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

About UK Ucommune International Ltd

Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. Company provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has three operating segments: Workspace membership, Marketing and branding services, and Other services. Marketing and branding services generate the majority of the company's revenue.

Share on Social Networks: